Page last updated: 2024-09-05

anidulafungin and galactose

anidulafungin has been researched along with galactose in 4 studies

Compound Research Comparison

Studies (anidulafungin)	Trials (anidulafungin)	Recent Studies (post-2010) (anidulafungin)	Studies (galactose)	Trials (galactose)	Recent Studies (post-2010) (galactose)
568	33	331	18,988	193	4,605

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ	1
Cuenca-Estrella, M; Gurguí, M	1
Bow, EJ; Cornely, OA; Heinz, WJ; Herbrecht, R; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Maertens, JA; Marr, KA; Nucci, M; Pappas, PG; Queiroz-Telles, F; Rottinghaus, ST; Schlamm, HT; Selleslag, D; Slavin, MA; Walsh, TJ; Wingard, JR	1
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X	1

Reviews

1 review(s) available for anidulafungin and galactose

Article	Year
[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections	2008

Article

Year

[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].

Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14

Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections

2008

Trials

2 trial(s) available for anidulafungin and galactose

Article	Year
Combination antifungal therapy for invasive aspergillosis: a randomized trial. Annals of internal medicine, 2015, Jan-20, Volume: 162, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult	2015
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data. BMC infectious diseases, 2019, May-28, Volume: 19, Issue:1 Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole	2019

Article

Year

Combination antifungal therapy for invasive aspergillosis: a randomized trial.

Annals of internal medicine, 2015, Jan-20, Volume: 162, Issue:2

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult

2015

Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.

BMC infectious diseases, 2019, May-28, Volume: 19, Issue:1

Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole

2019

Other Studies

1 other study(ies) available for anidulafungin and galactose

Article	Year
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole	2009

Article

Year

Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.

Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole

2009